Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D. K. A. Scheller"'
Publikováno v:
Journal of Neural Transmission. 118(12):1691-1702
The treatment of the motor symptoms of Parkinson's disease (PD) is dependent on the use of dopamine replacement therapy in the form of L: -dopa and dopamine agonist drugs. However, the development of dyskinesia (chorea, dystonia, athetosis) can becom
Publikováno v:
Journal of Neural Transmission. 118:1717-1725
Continuous dopaminergic treatment is considered to prevent or delay the occurrence of dyskinesia in patients with Parkinson's disease (PD). Rotigotine is a non-ergolinic D(3) D(2) D(1) dopamine-receptor agonist for the treatment of PD using a transde
Autor:
D. K. A. Scheller, Lance A. Smith, Peter Jenner, Sarah Rose, Mahmoud M. Iravani, Michael J. Jackson, K. Stockwell
Publikováno v:
Experimental Neurology. 221:79-85
We previously showed that continuous infusion of rotigotine resulted in less dyskinesia than repeated pulsatile rotigotine administration or repeated oral administration of L-DOPA in MPTP-treated marmosets. Now we investigate whether continuous rotig
Publikováno v:
Journal of Neural Transmission. 114:1027-1031
Rotigotine, a non-ergolinic dopamine receptor agonist for treatment of Parkinson's disease was continuously administered over 48 h (0.5 mg/kg s.c., slow release formulation) to conscious rats striatally implanted with a microdialysis probe. Subsequen